Please login to the form below

Not currently logged in

Titan Pharmaceuticals

This page shows the latest Titan Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan Pharma and Braeburn Pharma's Probuphine.

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    An FDA panel has backed approval of a long-acting buprenorphine implant for the management of opioid addiction developed by Titan Pharma and partner Braeburn Pharma. ... Titan and Braeburn attempted to secure US approval for their product in 2013 but

  • US launch for Novartis' Fanapt

    Fanapt was originally developed by Titan Pharmaceuticals, but then under the license agreement from Novartis, Vanda Pharmaceuticals undertook to pursue the drug's phase III development programme and complete product registration. ... America, CEO,

  • Lack of treatments depress EU bladder cancer market

    Fenretinide. Vitamin A analogue. NCI. III. Gallium maltolate. Gallium (semi-metalic). Titan Pharmaceuticals. ... DUSA Pharmaceuticals. II. MCC (urocidin). Mycobacterial cell wall-DNA complex. Bioniche Life Sciences.

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

    Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney has joined Titan Pharmaceuticals’ board of directors, where she currently serves as executive vice president and chief scientific officer. ... DeVarney joined Titan over

  • Ex-Bayer R&D chief joins Gemmus Pharma board

    Rubin is currently executive chairman of Titan Pharmaceuticals and previously served as head of global research and development for Bayer Schering Pharma. ... His past positions include chairman of Schering Berlin and president of Schering AG's Berlex

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...